Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981106194> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1981106194 endingPage "192" @default.
- W1981106194 startingPage "189" @default.
- W1981106194 abstract "Abstract Anti‐RNA polymerase III antibody (RNAP) is primarily detected in diffuse cutaneous type systemic sclerosis (dcSSc) patients and strongly associated with renal crisis. Additionally, there has been increasing evidence that cancer in SSc patients is associated with RNAP. The aim of this study was to examine the demographic and clinical features of SSc patients with RNAP. Among 246 SSc patients, 5.7% were positive for RNAP, 20.7% were positive for anti‐topoisomerase I antibody (Topo I) alone and 39.4% were positive for anticentromere antibody (ACA) alone. The modified Rodnan total skin score (mRTSS) in SSc patients with RNAP (19.1 ± 2.6) was significantly higher than those in SSc patients with Topo I (11.5 ± 1.1) and patients with ACA (4.4 ± 0.4). Furthermore, among SSc patients with RNAP, the levels of RNAP were positively correlated with mRTSS. Renal crisis is also significantly more prevalent in SSc patients with RNAP than patients without RNAP. Male sex, dcSSc subtype, digital vasculopathy, including digital ulcers and acro‐osteolysis, interstitial lung disease and rheumatoid arthritis complications were prevalent in SSc patients with RNAP and patients with Topo‐I. Primary biliary cirrhosis and Sjögren's syndrome were more in SSc patients with RNAP and patients with ACA compared with patients with Topo 1. No significant difference in the frequency of complications, including Raynaud's phenomenon, pulmonary artery hypertension and malignancy was observed between the three groups. Thus, measurement of RNAP in SSc patients is useful for the diagnosis and risk stratification of severe manifestation, such as renal crisis and severe skin sclerosis." @default.
- W1981106194 created "2016-06-24" @default.
- W1981106194 creator A5006756526 @default.
- W1981106194 creator A5008903485 @default.
- W1981106194 creator A5030622546 @default.
- W1981106194 creator A5044927587 @default.
- W1981106194 creator A5082094461 @default.
- W1981106194 date "2014-12-06" @default.
- W1981106194 modified "2023-09-27" @default.
- W1981106194 title "Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies" @default.
- W1981106194 cites W1995217206 @default.
- W1981106194 cites W2024346357 @default.
- W1981106194 cites W2028921539 @default.
- W1981106194 cites W2035705144 @default.
- W1981106194 cites W2050702365 @default.
- W1981106194 cites W2056293311 @default.
- W1981106194 cites W2083719119 @default.
- W1981106194 cites W2092116344 @default.
- W1981106194 cites W2132187544 @default.
- W1981106194 cites W2132669051 @default.
- W1981106194 cites W2146597908 @default.
- W1981106194 cites W2161082940 @default.
- W1981106194 cites W2161603955 @default.
- W1981106194 cites W2165416097 @default.
- W1981106194 doi "https://doi.org/10.1111/1346-8138.12722" @default.
- W1981106194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25483258" @default.
- W1981106194 hasPublicationYear "2014" @default.
- W1981106194 type Work @default.
- W1981106194 sameAs 1981106194 @default.
- W1981106194 citedByCount "13" @default.
- W1981106194 countsByYear W19811061942016 @default.
- W1981106194 countsByYear W19811061942017 @default.
- W1981106194 countsByYear W19811061942018 @default.
- W1981106194 countsByYear W19811061942019 @default.
- W1981106194 countsByYear W19811061942020 @default.
- W1981106194 countsByYear W19811061942021 @default.
- W1981106194 countsByYear W19811061942022 @default.
- W1981106194 crossrefType "journal-article" @default.
- W1981106194 hasAuthorship W1981106194A5006756526 @default.
- W1981106194 hasAuthorship W1981106194A5008903485 @default.
- W1981106194 hasAuthorship W1981106194A5030622546 @default.
- W1981106194 hasAuthorship W1981106194A5044927587 @default.
- W1981106194 hasAuthorship W1981106194A5082094461 @default.
- W1981106194 hasConcept C126322002 @default.
- W1981106194 hasConcept C159654299 @default.
- W1981106194 hasConcept C203014093 @default.
- W1981106194 hasConcept C2777543607 @default.
- W1981106194 hasConcept C2777575956 @default.
- W1981106194 hasConcept C2777714996 @default.
- W1981106194 hasConcept C71924100 @default.
- W1981106194 hasConcept C90924648 @default.
- W1981106194 hasConceptScore W1981106194C126322002 @default.
- W1981106194 hasConceptScore W1981106194C159654299 @default.
- W1981106194 hasConceptScore W1981106194C203014093 @default.
- W1981106194 hasConceptScore W1981106194C2777543607 @default.
- W1981106194 hasConceptScore W1981106194C2777575956 @default.
- W1981106194 hasConceptScore W1981106194C2777714996 @default.
- W1981106194 hasConceptScore W1981106194C71924100 @default.
- W1981106194 hasConceptScore W1981106194C90924648 @default.
- W1981106194 hasIssue "2" @default.
- W1981106194 hasLocation W19811061941 @default.
- W1981106194 hasLocation W19811061942 @default.
- W1981106194 hasOpenAccess W1981106194 @default.
- W1981106194 hasPrimaryLocation W19811061941 @default.
- W1981106194 hasRelatedWork W2045151582 @default.
- W1981106194 hasRelatedWork W2082406232 @default.
- W1981106194 hasRelatedWork W2156283049 @default.
- W1981106194 hasRelatedWork W2316954211 @default.
- W1981106194 hasRelatedWork W2326094713 @default.
- W1981106194 hasRelatedWork W2427075784 @default.
- W1981106194 hasRelatedWork W2617939361 @default.
- W1981106194 hasRelatedWork W2761967325 @default.
- W1981106194 hasRelatedWork W4210646529 @default.
- W1981106194 hasRelatedWork W4238056209 @default.
- W1981106194 hasVolume "42" @default.
- W1981106194 isParatext "false" @default.
- W1981106194 isRetracted "false" @default.
- W1981106194 magId "1981106194" @default.
- W1981106194 workType "article" @default.